Liraglutide ameliorates diabetic lung injury and muscle damage via modulation of TLR4/NF-κB and Atrogin-1/AMPK signaling pathways.

Saved in:
Bibliographic Details
Title: Liraglutide ameliorates diabetic lung injury and muscle damage via modulation of TLR4/NF-κB and Atrogin-1/AMPK signaling pathways.
Authors: Mohammed MA; Department of Medical Physiology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt. marwadawaa1@gmail.com., Yousef MA; Department of Anatomy, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt., Abdelmohymen AM; Department of Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt., Mostafa SM; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt., Reyad HR; Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt., Abdelfattah SF; Department of Pharmacology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt., Rateb EE; Department of Medical Physiology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Source: Molecular biology reports [Mol Biol Rep] 2026 May 26; Vol. 53 (1). Date of Electronic Publication: 2026 May 26.
Publication Type: Journal Article
Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-4978
DOI:10.1007/s11033-026-11978-6